— Know what they know.
Not Investment Advice

BCEL NASDAQ

Atreca, Inc.
1W: +0.0% 1M: -4.3% 3M: -47.1% 1Y: -91.8% 3Y: -99.1%
$0.09
Last traded 2024-06-14 — delisted
NASDAQ · Healthcare · Biotechnology · $3.6M mcap · 28M float · 0.617% daily turnover

Cash Flow Trends

Operating Cash Flow
-$81M -32.5% ▼
Capital Expenditures
$885K +97.5% ▲
5Y CAGR: -8.5%
Free Cash Flow
-$82M +15.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$64M -290.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$38M-$67M-$86M-$109M-$97M
Depreciation & Amort.$1M$2M$2M$5M$7M
Stock-Based Comp.$0$6M$12M$17M$17M
Change in Working Capital$378K$2M$4M$25M-$8M
Other Non-Cash Items$34K-$555K$326K$2M$505K
Operating Cash Flow-$35M-$59M-$67M-$61M-$81M
— Investing Activities —
Capital Expenditures-$2M-$3M-$5M-$35M-$885K
Acquisitions (Net)$0$0$0-$124K-$13K
Investment Purchases$0-$100M-$250M-$54M-$62M
Investment Sales$22M$75M$96M$178M$76M
Other Investing$24K$189K$127K$124K$13K
Investing Cash Flow$21M-$28M-$159M$89M$13M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$133K$1M$0$0
Dividends Paid$0$0$0$0$0
Other Financing$120M$131M$129M$5M$4M
Financing Cash Flow$120M$131M$129M$5M$4M
Net Change in Cash$106M$45M-$97M$34M-$64M
Cash End of Period$115M$159M$62M$96M$32M
Free Cash Flow-$36M-$62M-$72M-$96M-$82M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms